Buserelin Acetate (Suprefact®)

Buserelin Acetate (SuCommon name: Buserelin Acetate
Brand name: Suprefact®


What is Buserelin Acetate?

Buserelin Acetate is a luteinizing hormone releasing hormone (LHRH) analogue that is used in the palliative treatment of advanced (metastatic) prostate cancer. Buserelin acetate works by blocking the production of testosterone which reduces the growth and reproduction of prostate cancer cells.
 

How is Buserelin Acetate administered?

Buserelin Acetate is by administered by subcutaneous injection or as a nasal solution.
 

What are possible side effects of this treatment?

Everyone responds differently to hormone therapy – some experience many side effects while others experience very few. Below are some side effects experienced by those who received buserelin acetate. Tell your health care team about side-effects you are experiencing so they know how best to help you manage them.
 
  • Diarrhea
  • Dizziness
  • Dry mouth
  • Hot flashes
  • Impotence (erectile dysfunction)
  • Nausea / vomiting
  • Reduced sexual desire (low libido)


Is Buserelin Acetate covered in my province or territory?

Buserelin acetate is covered by provincial drug programs in:
  • Alberta
  • British Columbia
  • Manitoba
  • New Brunswick
  • Newfoundland & Labrador
  • Nova Scotia
  • Ontario
  • Quebec
  • Saskatchewan
  • Nunavut
  • Northwest Territories
  • Yukon
Buserelin acetate is not covered by provincial drug programs in:
  • Prince Edward Island
 
Last Reviewed: July 2017

 
   
   

Plaid for Dad


Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Honouring dad this Father’s Day the Canadian way: In plaid

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer.
More

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.
More

Landmark study links tumour evolution to prostate cancer severity

Toronto (April 19, 2018) – Findings from Canadian Prostate Cancer Genome Network (CPC-GENE) researchers and their collaborators, published today in Cell, show that the aggressiveness of an individual prostate cancer can be accurately assessed by looking at how that tumour has evolved.
More


Click here for news archive